SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
The latest dividend from SIGA was $0.60 per share (ex-dividend 4/7/2026). The dividend yield over the last 12 months is 17,6%. Over the last 12 months there was 1 distribution, totalling $0.60 per share.